Pushkal Garg
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Pushkal Garg
The proxy statement of Alnylam Pharmaceuticals, Inc. reports total compensation of $6,490,500 for Pushkal Garg in fiscal 2025, including a base salary of $767,900. Disclosed compensation is on record for 6 fiscal years. Pushkal Garg has spoken on 1 earnings call and 2 other investor events across 1 company, most recently for Alnylam Pharmaceuticals, Inc. on June 9, 2026.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Alnylam Pharmaceuticals, Inc. (ALNY)
Proxy statement
CurrentStart not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Alnylam Pharmaceuticals, Inc.
Other people whose current roles at this company are on record from its filings.
- Yvonne Greenstreet CEO, COO
- Yvonne L. Greenstreet CEO, COO, Board Member
- Amy W. Schulman Chairman, Board Member
- Michael Bonney Chairman
- Michael W. Bonney Chairman
- Jeffrey Poulton CFO
- Manmeet S CFO
- Akshay K. Vaishnaw, M.D., Ph.D. CIO
- Benjamin F. Cravatt Board Member
- Benjamin F. Cravatt, Ph.D. Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Alnylam Pharmaceuticals, Inc. (ALNY) | Executive Vice President, Chief Research and Development Officer | $767,900 | $6,490,500 |
| 2024 | Alnylam Pharmaceuticals, Inc. (ALNY) | Executive Vice President, Chief Medical Officer | $682,100 | $2,919,190 |
| 2023 | Alnylam Pharmaceuticals, Inc. (ALNY) | Executive Vice President, Chief Medical Officer | $656,900 | $3,231,090 |
| 2022 | Alnylam Pharmaceuticals, Inc. (ALNY) | Executive Vice President, Chief Medical Officer | $625,000 | $2,900,580 |
| 2021 | Alnylam Pharmaceuticals, Inc. (ALNY) | Executive Vice President, Chief Medical Officer | $568,900 | $4,047,990 |
| 2020 | Alnylam Pharmaceuticals, Inc. (ALNY) | Chief Medical Officer and Executive Vice President, Development & Medical Affairs | $553,200 | $2,587,750 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.